A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Sintilimab; Drug: Chemotherapy Sponsors: Fudan University; Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials